$5.05
0.79% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US9216591084
Symbol
VNDA
Sector
Industry

Vanda Pharmaceuticals Inc. Stock price

$5.05
+0.50 10.99% 1M
-0.18 3.44% 6M
+0.83 19.67% YTD
+1.49 41.85% 1Y
-12.28 70.86% 3Y
-11.48 69.45% 5Y
-7.64 60.20% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.04 0.79%
ISIN
US9216591084
Symbol
VNDA
Sector
Industry

Key metrics

Market capitalization $294.46m
Enterprise Value $-73.86m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 4.06
EV/Sales (TTM) EV/Sales -0.39
P/S ratio (TTM) P/S ratio 1.54
P/B ratio (TTM) P/B ratio 0.54
Revenue growth (TTM) Revenue growth -9.91%
Revenue (TTM) Revenue $190.86m
EBIT (operating result TTM) EBIT $-37.48m
Free Cash Flow (TTM) Free Cash Flow $-18.20m
Cash position $376.26m
EPS (TTM) EPS $-0.28
P/E forward negative
P/S forward 1.48
EV/Sales forward negative
Short interest 8.25%
Show more

Is Vanda Pharmaceuticals Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Vanda Pharmaceuticals Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

3 Analysts have issued a Vanda Pharmaceuticals Inc. forecast:

2x Buy
67%
1x Hold
33%

Analyst Opinions

3 Analysts have issued a Vanda Pharmaceuticals Inc. forecast:

Buy
67%
Hold
33%

Financial data from Vanda Pharmaceuticals Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
191 191
10% 10%
100%
- Direct Costs 19 19
2% 2%
10%
172 172
11% 11%
90%
- Selling and Administrative Expenses 123 123
3% 3%
65%
- Research and Development Expense 79 79
11% 11%
41%
-30 -30
1,417% 1,417%
-16%
- Depreciation and Amortization 7.32 7.32
190% 190%
4%
EBIT (Operating Income) EBIT -37 -37
16,265% 16,265%
-20%
Net Profit -16 -16
239% 239%
-9%

In millions USD.

Don't miss a Thing! We will send you all news about Vanda Pharmaceuticals Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Vanda Pharmaceuticals Inc. Stock News

Neutral
PRNewsWire
14 days ago
WASHINGTON , Nov. 12, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the following upcoming investor conferences in November 2024: The Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024. A corporate presentation is scheduled for 9:45 a.m.
Neutral
Seeking Alpha
19 days ago
Vanda Pharmaceuticals Inc. (VNDA) Q3 2024 Earnings Call Transcript
Neutral
PRNewsWire
20 days ago
Revenues for Q3 2024 were $47.7 million, an increase of 23% compared to Q3 2023 Financial Guidance revised for Full Year 2024, raising the midpoint of revenue and cash ranges Fanapt® launch in bipolar I disorder; new patient starts increased by over 90% in Q3 2024 as compared to Q3 2023 Fanapt® long acting injectable program expected to be initiated in Q4 2024 Milsaperidone NDA for schizophreni...
More Vanda Pharmaceuticals Inc. News

Company Profile

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Head office United States
CEO Mihael Polymeropoulos
Employees 203
Founded 2002
Website www.vandapharma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today